Escalon Medical logo

Escalon Medical(OTC) ESMC

Market Cap$1.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-100%
5 Year+4%
1 Year+6%
1 Month+10%
$0.17
-2.86%
-0.00Today
Escalon Medical last closing stock price
MetricPriceDate
Last closeUSD 0.172026-10-16
Escalon Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+13.18%USD 0.152026-10-08
1 month+9.68%USD 0.162026-09-16
3 month-15%USD 0.202026-07-17
Year to date+1.25%USD 0.172025-12-31
1 year+6.25%USD 0.162025-10-16
3 year-43.33%USD 0.302023-10-17
5 year+3.6%USD 0.162021-10-15
Since inception-99.8%USD 85.001992-09-11

Escalon Medical Financials at a Glance

Market Cap

$1.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.74M

Net Income (TTM)

$4.01M

EPS (TTM)

$0.25

P/E Ratio

0.67

Dividend

$0.00

Beta (Volatility)

0.13 (Low)

Price

$0.17

Volume

70,000

Open

$0.17

Previous Close

$0.17

Daily Range

$0.17 - $0.18

52-Week Range

$0.14 - $0.29

Estimated Earnings Date

May 15, 2026

ESMC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Escalon Medical

Escalon makes devices and supplies for eye doctors and surgeons. Its products help diagnose and treat eye conditions, like measuring eye structure or supporting retina surgery. Hospitals and clinics use these tools to improve patient care and manage eye health.

Eye-Openers: Products and Services

  • Ophthalmic Ultrasound Devices: Tools like A-Scan and B-Scan help doctors see inside the eye; main revenue driver (exact percentage not disclosed).
  • Surgical Gas Products: Gases such as C3F8 and SF6 are used in retina surgeries; Trek brand saw revenue rise by $546,000 for nine months ended March 2025.
  • Disposable Surgical Packs: Single-use kits for eye surgeries, targeting hospitals and surgical centers.
  • Image Management Software: AXIS system lets clinics store and access eye images from different devices; revenue up $83,000 for nine months ended March 2025.
  • Patented Gas Delivery Kits: Universal kits for safely delivering surgical gases to patients during eye procedures.

Growth Spurts: Expansion Moves

  • Expanded product lines in ultrasound and image management since 2023, focusing on new features and updates.
  • Extended Wisconsin facility lease to April 2028 to support ongoing operations.
  • Increased international sales, with foreign revenue at 44.9% of total for nine months ended March 2025.
  • Implemented cost-cutting and efficiency programs in 2024 and 2025 to address operational risks.

What Makes Escalon Stand Out

Escalon combines hardware and software for eye care, serving both U.S. and international markets. Its multi-channel sales approach uses independent reps, distributors, and internal teams. Proprietary products, like the universal gas kit, add differentiation in a specialized field.

Five Things You Need to Know

  • Net revenue was $9.5 million for nine months ended March 2025, up 11.4% year-over-year.
  • Operating income was $505,000 for nine months ended March 2025, compared to a loss last year.
  • International sales made up 44.9% of total revenue for nine months ended March 2025.

Bottom Line

Escalon has evolved by expanding its product range and improving efficiency. The company remains focused on specialized eye care tools and international growth.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

40

CEO

Richard J. DePiano, Jr.

Website

www.escalonmed.com

Headquarters

Wayne, PA 19087, US

ESMC Financials

Key Financial Metrics (TTM)

Gross Margin

43.73%

Operating Margin

0.36%

Net Income Margin

31.51%

Return on Equity

118.70%

Return on Capital

0.01%

Return on Assets

0.04%

Earnings Yield

1.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.42M

Volume

70.00K

Avg. Volume

8.33K

Financials (TTM)

Gross Profit

$5.57M

Operating Income

$45.24K

EBITDA

$35.03K

Operating Cash Flow

$29.37M

Capital Expenditure

-$4.41K

Free Cash Flow

$29.37M

Cash & ST Invst.

$3.07B

Total Debt

$836.84M

Escalon Medical Performance Analysis

Escalon Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30USD 12,180,22113.8%
20242024-06-30USD 11,981,509-1.6%
20252025-06-30USD 12,046,1480.5%
20262026-06-30USD 12,736,1455.7%
Escalon Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-304.1%
Q22025-12-3134.2%
Q32026-03-31-27.4%
Q42026-06-3048.0%
Escalon Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30USD 0.03N/A
20242024-06-30USD -0.02N/A
20252025-06-30USD 0.00N/A
20262026-06-30USD 0.277042.1%
Escalon Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30-23.1%
Q22025-12-31117.3%
Q32026-03-312611.9%
Q42026-06-30-25.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$3.86M

+50.2%

Gross Profit

$1.95M

+73.1%

Gross Margin

50.41%

N/A

Market Cap

$1.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$31.52K

N/A

Employees

40

N/A

Net Income

$1.78M

+569.1%

EBITDA

$571.51K

+257.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$3.07B

+561510.7%

Total Debt

$836.84M

+159815.0%

Accounts Receivable

$1.90M

+26.6%

Inventory

$1.73B

+80841.7%

Long Term Debt

$677.19M

+172343.0%

Short Term Debt

$160.49M

+122784.1%

Return on Assets

0.04%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$251.18M

-2114446.9%

Operating Cash Flow

-$251.18M

-1593881.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVFMEvofem Biosciences, Inc.
$0.01+0.00%
MJNAMedical Marijuana, Inc.
$0.00+0.00%
NSTMNovelStem International Corp.
$0.01+0.00%
CYDXCYduct Diagnostics, Inc.
$0.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About ESMC

What is the current price of Escalon Medical?

Escalon Medical is trading at $0.17 per share.

What is the 52-week range for Escalon Medical?

Over the past 52 weeks, Escalon Medical has traded between $0.14 and $0.29.

How much debt does Escalon Medical have?

As of the most recent reporting period, Escalon Medical reported total debt of $974.74K.

How much cash does Escalon Medical have on hand?

Escalon Medical reported $3.07M in cash and cash equivalents in its most recent financial results.

What is Escalon Medical’s dividend yield?

Escalon Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services